pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-04×clear all
type
  • 8k filing3,350
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
device pma
236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 16, 2026

    50
    ›Mar 18, 2026approval152d agoVIGABATRIN — FDA approvalVIGABATRIN

    Sponsor: AUROBINDO PHARMA LTD. Form: FOR SOLUTION. Route: ORAL

    full page →VIGABATRIN →fda approvals ↗
    ›Mar 18, 2026recall152d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7 — Reason: Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 18, 2026device 510k152d agoLimFlow, Inc. — LimFlow Vector (510k cleared)

    Product code: MGZ. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoVarian Medical Systems, Inc. — syngo.via RT Image Suite VC10 (510k cleared)MERIT MEDICAL SYSTEMS INC

    Product code: MUJ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoO&M Halyard, Inc. — HALYARD* FLUIDSHIELD* 3 Fog-Free Procedure Mask with SO SOFT* Lining and SO SOFT* Earloops; HALYARD* FLUIDSHIELD* 3 Fog-Free Procedure Mask with SO SOFT* Lining and SO SOFT* Earloops with WrapAround Visor (510k cleared)

    Product code: FXX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoMedShape, Inc. — DynaNail Mini; DynaNail Hybrid; DynaNail Helix; DynaClip; DynaClip Forte; DynaClip Delta; DynaClip Quattro (510k cleared)

    Product code: HWC. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoVision Rt, Ltd. — AlignRT Plus (8.0) (510k cleared)Rail Vision Ltd.

    Product code: IYE. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoFusion Orthopedics USA, LLC — Fusion FibFix Nail (510k cleared)

    Product code: HSB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoMiRus, LLC — EUROPA™ Posterior Cervical Fusion Navigated Instruments (510k cleared)

    Product code: OLO. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoNingbo Medsun Medical Co., Ltd. — Safety Pen Needle (510k cleared)

    Product code: FMI. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoSangi Co., Ltd. — APAPRO Desensitizer Homecare (Remineralizing Anti-sensitivity Toothpaste) (510k cleared)SanBio Co Ltd

    Product code: LBH. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device 510k152d agoCarl Zeiss Vision GmbH — VISUREF 600 (510k cleared)

    Product code: HJO. Advisory committee: Ophthalmic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 18, 2026device pma152d agoMedtronic Neuromodulation — InterStim® Therapy System, Verify® Evaluation System (SNS Urinary Neurostimulator) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoMerz North America, Inc. — RADIESSE® Injectable Implant (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LMH. Advisory committee: SU. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoBoston Scientific — INGEVITY™+ Pace / Sense Lead – Tined Fixation Models 7831 (52 cm, Straight) 7832 (59 cm, Straight) 7835 (45 cm, Atrial J (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Normal 180 Day Track. Product code: LWP. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoMedtronic Neuromodulation — InterStim® Therapy System, Verify® Evaluation System (SNS Bowel Neurostimulator) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoMerz North America, Inc. — COAPTITE® Injectable Implant (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LNM. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoMerz North America, Inc. — RADIESSE® Injectable Implant (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LMH. Advisory committee: SU. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoCooperVision, Inc. — Biofinity Sphere, Biofinity XR Sphere, Biofinity Energys, Biofinity Toric, Biofinity XR Toric, Biofinity Multifocal; Bio (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoLivaNova USA, Inc. — aura6000™ system (PMA)

    Product code: MNQ. Advisory committee: AN. Decision: APPR

    full page →fda device pma ↗
    ›Mar 18, 2026device pma152d agoCarl Zeiss Meditec Production, LLC — CT LUCIA 602; CT LUCIA 202; CT LUCIA 611P; CT LUCIA 621P (PMA supplement)

    Supplement type: 30-Day Notice. Product code: HQL. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Mar 18, 2026grant152d agoCALIFORNIA STATE UNIVERSITY NORTHRIDGE — Expanding Access to Digital Health Technologies Through Equity-Centered Engin...

    EB grant. $21,072. PI: Thomas Chan

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoSMITH COLLEGE — Effects of children's early experience with varying parental styles on the ne...

    HD grant. $527,648. PI: Maya Rosen

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoDUKE UNIVERSITY — Mechanisms of microbial regulation of postnatal growth and lipid metabolismDuke University

    DK grant. $612,587. PI: Noelle Elizabeth Younge

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoMASSACHUSETTS INSTITUTE OF TECHNOLOGY — Life-spanning study of Polycomb regulation by cohesin

    AG grant. $51,038. PI: Emily Navarrete

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Investigating Dead Cell-Phagocyte Interaction at the Phagosomal Interface to ...

    GM grant. $423,352. PI: Kai Li

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoJOHNS HOPKINS UNIVERSITY — Mechanobiological regulations of collective cell movement: insights from in v...Johns Hopkins University

    GM grant. $412,124. PI: Shinuo Weng

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Targeting Lethal mCRPC with siRNA TherapeuticsUniversity of California San Diego

    CA grant. $410,933. PI: STEVEN F DOWDY

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Epigenetic Regulation of Hypothalamic Energy Homeostasis

    DK grant. $664,240. PI: Isin Cakir

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoAUBURN UNIVERSITY AT MONTGOMERY — BRE-SPAD at Auburn University at Montgomery

    GM grant. $554,945. PI: Douglas W Leaman

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Novel targeted combinatorial therapy for castration-resistant prostate cancer

    CA grant. $658,492. PI: Song Li

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUT SOUTHWESTERN MEDICAL CENTER — Lipid Droplets

    DK grant. $25,000. PI: Mike Henne

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Progressive Clinical Team-Based Design and Skill-Building Across All Undergra...University of California San Diego

    EB grant. $21,600. PI: Reem Khojah

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoSTANFORD UNIVERSITY — Threading the needle: Development of Novel MR Methods for Effective Control o...Stanford University

    CA grant. $593,557. PI: Lawrence D Recht

    full page →nih reporter ↗
    ›Mar 18, 2026grant152d agoUNIVERSITY OF MARYLAND BALTIMORE — Associations between actigraphy-derived circadian rest-activity rhythms and c...

    CA grant. $411,334. PI: Amber Simmons Kleckner

    full page →nih reporter ↗
    ›Mar 19, 2026approval151d agoDUOPA (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ABBVIE. Form: SUSPENSION. Route: ENTERAL

    full page →carbidopa →fda approvals ↗
    ›Mar 19, 2026approval151d agoRIFAXIMIN — FDA approvalSalix Pharmaceuticals Ltd

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoRIFABUTIN — FDA approvali3 Pharmaceuticals LLC

    Sponsor: I3 PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoSTALEVO 75 (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL

    full page →carbidopa →fda approvals ↗
    ›Mar 19, 2026approval151d agoVYALEV (FOSCARBIDOPA) — FDA approval(foscarbidopa + foslevodopa)

    Sponsor: ABBVIE. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →(foscarbidopa + foslevodopa) →fda approvals ↗
    ›Mar 19, 2026approval151d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoOPUVIZ (AFLIBERCEPT-YSZY) — FDA approvalOPUVIZ

    Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION

    full page →OPUVIZ →fda approvals ↗
    ›Mar 19, 2026approval151d agoVALGANCICLOVIR HYDROCHLORIDE — FDA approvalVALGANCICLOVIR HYDROCHLORIDE

    Sponsor: MICRO LABS. Form: FOR SOLUTION. Route: ORAL

    full page →VALGANCICLOVIR HYDROCHLORIDE →fda approvals ↗
    ›Mar 19, 2026approval151d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoFLAVALTA (EPINEPHRINE BITARTRATE) — FDA approvalDe Motu Cordis Pty Ltd

    Sponsor: DEPROCO. Form: SOLUTION. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoDHIVY (CARBIDOPA) — FDA approvalAvion Pharmaceuticals LLC

    Sponsor: AVION PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoRYTARY (CARBIDOPA) — FDA approvalOrganon & Co.

    Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 19, 2026approval151d agoDEXMETHYLPHENIDATE HYDROCHLORIDE — FDA approvaldexmethylphenidate hydrochloride ER

    Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →dexmethylphenidate hydrochloride ER →fda approvals ↗
    ›Mar 19, 2026approval151d agoDEXMETHYLPHENIDATE HYDROCHLORIDE — FDA approvaldexmethylphenidate hydrochloride ER

    Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →dexmethylphenidate hydrochloride ER →fda approvals ↗
    ›Mar 19, 2026approval151d agoDEXMETHYLPHENIDATE HYDROCHLORIDE — FDA approvaldexmethylphenidate hydrochloride ER

    Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →dexmethylphenidate hydrochloride ER →fda approvals ↗
    ← prev
    page 16 of 149
    next →
    $LBRX47.77+7.92%
    $MMSI90.76+0.29%
    $RVSN4.4000-4.56%
    $ORN12.42-2.13%
    $BSX51.83+0.27%
    $ABBV249.46-0.54%
    $OGN13.72+0.15%
    $ABBV249.46-0.54%